Reason reports back from Rejuvenation Startup Summit 2024
Fight Aging! - 13-May-2024A great summary of 25 speakers who are in various stages of platform building, drug discovery and clinical trials
Join the club for FREE to access the whole archive and other member benefits.
Daily news and insights on research, investments and technologies on life extension
We bring together innovators and investors to commercialise the companies that will form the longevity economy.
There are already 100+ rejuvenation biotechs working on unique therapies and building R&D pipelines to increase healthspan and lifespan.
At the same time, all around the world, innovators are releasing nanobots, reprogramming nerve signals and applying AI to create exciting and scalable contributions to human Longevity.
Visit website: https://www.longevity.technology/
Details last updated 12-Sep-2019
A great summary of 25 speakers who are in various stages of platform building, drug discovery and clinical trials
Longevity.Technology releases its annual longevity investment report 2023
Key investors raise funding to support longevity sector
18-Jan-2023
Phil talks about shaping the longevity industry at this Oxford Society of Ageing and Longevity event (FREE)
Longevity Technology discusses senescent cells with Steve Matheson, CEO of Combilytics (YouTube)
Biotech startup Elevara aims to transform RA treatment with a non-immunosuppressive oral drug
NewLimit’s $45M raise advances youthful liver and immune cell restoration in preclinical studies
PP405 shows early promise in reactivating dormant hair follicles to restore growth
Trials showed fewer hospital visits and faster access to care
Interim trials show improved weight, muscle, and vitality in aging cats with TCHC therapies
Partnership aims to uncover disease-driving genes and boost precision drug development
Cirrus Therapeutics targets aging biology to combat blindness from dry AMD
Startup scaled cryopreservation from neural slices to large-animal organs, eyeing human trials
First BioAgent generated 1,000+ hypotheses, raised $900K, and drove lab testing within weeks
New multi-agent AI analyzes massive datasets to predict biological age in weeks, not years
Using donated organs, Revalia aims to cut drug failures and speed safe treatments to patients
Funding backs trials of NRG5051, aiming to slow ALS and Parkinson’s by protecting neurons
Experimental RNAi drug aims to silence alpha-synuclein and slow neurodegeneration
$350K grant fuels Minovia’s biomarker work, as early trials show promising patient gains
Startup uses AI to explore billions of molecules for next-gen skincare innovation
New funding will help expand OneSkin’s reach and target ageing at the cellular level
With $19 million funding, the startup plans regulatory approvals and scaling
The fund bridges East-West collaboration and acts quickly using its own capital
New investment fuels development of therapies targeting mtDNA-related energy disorders
Epigenica launches scalable tech to decode epigenetic ageing and disease markers